Not Rated
|
Fund Size
(0.02% of Investment in Category)
|
Expense Ratio
(2.12% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 13-Oct-25 | 10099.30 | 0.99% | - | 1.32% | 158/238 |
| 1 Month | 19-Sep-25 | 10040.60 | 0.41% | - | 0.15% | 94/235 |
| 3 Month | 18-Jul-25 | 10090.70 | 0.91% | - | 2.09% | 145/230 |
| 6 Month | 17-Apr-25 | 10699.50 | 7.00% | - | 11.04% | 184/224 |
| YTD | 01-Jan-25 | 9886.30 | -1.14% | - | 4.10% | 156/212 |
| 1 Year | 18-Oct-24 | 10048.90 | 0.49% | 0.49% | 0.39% | 87/195 |
| 2 Year | 20-Oct-23 | 15991.00 | 59.91% | 26.41% | 19.61% | 17/152 |
| 3 Year | 20-Oct-22 | 17413.80 | 74.14% | 20.29% | 19.71% | 53/127 |
| 5 Year | 20-Oct-20 | 19532.80 | 95.33% | 14.32% | 22.35% | 94/103 |
| Since Inception | 28-Feb-19 | 30178.20 | 201.78% | 18.08% | 12.86% | 56/217 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 18-Oct-24 | 12000 | 12506.91 | 4.22 % | 7.9 % |
| 2 Year | 20-Oct-23 | 24000 | 28041.93 | 16.84 % | 15.74 % |
| 3 Year | 20-Oct-22 | 36000 | 49208.5 | 36.69 % | 21.36 % |
| 5 Year | 20-Oct-20 | 60000 | 90915.77 | 51.53 % | 16.63 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 85.9 | 10.08% | 0.35% | 10.73% (May 2025) | 9.72% (Aug 2025) | 53.85 k | 0.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 49.8 | 5.85% | 0.05% | 5.85% (Sep 2025) | 2.91% (Nov 2024) | 6.72 k | 0.00 |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 47.3 | 5.55% | 0.26% | 5.55% (Sep 2025) | 4.91% (Oct 2024) | 13.13 k | 0.00 |
| Cipla Ltd. | Pharmaceuticals | 46.9 | 5.51% | -0.11% | 5.62% (Aug 2025) | 4.19% (Nov 2024) | 31.22 k | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 40.8 | 4.79% | 0.45% | 4.79% (Sep 2025) | 0% (Oct 2024) | 42.10 k | 0.00 |
| Piramal Pharma Ltd. | Pharmaceuticals | 37.9 | 4.45% | 0.33% | 7.55% (Oct 2024) | 3.73% (Jul 2025) | 1.98 L | 0.00 |
| Neuland Laboratories Ltd. | Pharmaceuticals | 35.3 | 4.14% | 0.46% | 4.24% (Nov 2024) | 3.11% (Apr 2025) | 2.41 k | 0.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 35 | 4.11% | -0.16% | 4.84% (May 2025) | 3.92% (Dec 2024) | 6.16 k | 0.00 |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 33.9 | 3.98% | 0.34% | 4.57% (Apr 2025) | 0% (Oct 2024) | 31.30 k | 0.00 |
| Alkem Laboratories Ltd. | Pharmaceuticals | 33.7 | 3.96% | 0.22% | 3.96% (Sep 2025) | 3.36% (Nov 2024) | 6.21 k | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 2.77% |
| Net Receivables | Net Receivables | -0.60% |
Ratios calculated on daily returns for last 3 years (Updated as on 30th September, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 406.67 | -1.55 | 23.65 | 77.62 | 36.14 | 42.17 |
| Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 266.19 | -0.79 | 6.38 | 23.19 | 26.49 | 19.12 |
| Nippon India Japan Equity Fund - Growth | NA | 289.73 | 0.00 | 6.24 | 16.59 | 21.43 | 19.61 |
| Quant BFSI Fund - Regular Plan - Growth | NA | 655.17 | 3.00 | 3.25 | 18.33 | 18.97 | 0.00 |
| SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 8693.07 | 3.85 | 3.27 | 9.73 | 17.95 | 19.60 |
| DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1419.62 | 3.42 | 2.78 | 8.35 | 17.90 | 0.00 |
| Franklin Asian Equity Fund - Growth | NA | 279.13 | 2.53 | 8.32 | 24.18 | 17.62 | 16.95 |
| HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1651.55 | -1.08 | 10.61 | 26.86 | 17.31 | 0.00 |
| ITI Banking and Financial Services Fund - Regular Plan - Growth | NA | 311.03 | 5.32 | 2.80 | 6.44 | 16.18 | 14.41 |
| Mirae Asset Banking and Financial Services Fund - Growth | NA | 2014.27 | 4.49 | 1.90 | 7.32 | 15.28 | 18.17 |
Out of 45 mutual fund schemes offered by this AMC, 2 is/are ranked 4 * , 10 is/are ranked 3 * , 10 is/are ranked 2 * , 5 is/are ranked 1 * , and 18 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| LIC MF Liquid Fund - Regular Plan - Growth | 2 | 11402.57 | 0.47 | 1.40 | 2.96 | 6.64 | 6.96 |
| LIC MF Money Market Fund - Regular Plan - Growth | NA | 3130.05 | 0.52 | 1.47 | 3.39 | 6.72 | 6.37 |
| LIC MF Large & Mid Cap Fund - Growth | 3 | 3046.84 | -0.14 | 0.29 | 8.26 | -1.28 | 16.61 |
| LIC MF Nifty 8-13 yr G-Sec ETF | NA | 2248.29 | 0.56 | 0.30 | 1.92 | 8.20 | 8.84 |
| LIC MF Nifty 8-13 yr G-Sec ETF | NA | 2248.29 | 0.58 | 0.35 | 1.99 | 8.38 | 9.08 |
| LIC MF Banking & PSU Fund - Growth | 3 | 1909.36 | 0.91 | 1.21 | 3.17 | 7.95 | 7.52 |
| LIC MF Multi Cap Fund - Regular Plan - Growth | NA | 1715.77 | 0.67 | 2.26 | 12.93 | 1.72 | 0.00 |
| LIC MF Low Duration Fund - Growth | 3 | 1705.18 | 0.53 | 1.45 | 3.41 | 7.53 | 7.54 |
| LIC MF Low Duration Fund - Growth | 3 | 1705.18 | 0.55 | 1.40 | 3.23 | 7.15 | 6.91 |
| LIC MF Large Cap Fund - Growth | 2 | 1445.32 | 0.87 | 2.02 | 6.44 | 1.58 | 12.79 |